234 related articles for article (PubMed ID: 22227586)
1. Reaping the prevention benefits of highly active antiretroviral treatment: policy implications of HIV Prevention Trials Network 052.
Forsyth AD; Valdiserri RO
Curr Opin HIV AIDS; 2012 Mar; 7(2):111-6. PubMed ID: 22227586
[TBL] [Abstract][Full Text] [Related]
2. Preventing HIV transmission through antiretroviral treatment-mediated virologic suppression: aspects of an emerging scientific agenda.
Dieffenbach CW
Curr Opin HIV AIDS; 2012 Mar; 7(2):106-10. PubMed ID: 22227584
[TBL] [Abstract][Full Text] [Related]
3. Treatment-for-prevention: clinical considerations.
Lockman S; Sax P
Curr Opin HIV AIDS; 2012 Mar; 7(2):131-9. PubMed ID: 22227588
[TBL] [Abstract][Full Text] [Related]
4. Using HIV viral load to guide treatment-for-prevention interventions.
Novitsky V; Essex M
Curr Opin HIV AIDS; 2012 Mar; 7(2):117-24. PubMed ID: 22258501
[TBL] [Abstract][Full Text] [Related]
5. HIV treatment as prevention and HPTN 052.
Cohen MS; McCauley M; Gamble TR
Curr Opin HIV AIDS; 2012 Mar; 7(2):99-105. PubMed ID: 22227585
[TBL] [Abstract][Full Text] [Related]
6. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
Panel de expertos de GESIDA y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
[TBL] [Abstract][Full Text] [Related]
7. Early antiretroviral therapy: the role of cohorts.
Sabin CA
Curr Opin HIV AIDS; 2009 May; 4(3):200-5. PubMed ID: 19532051
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral therapy for naïve and for treatment-experienced HIV patients, and prevention of HIV transmission.
Antunes F
Curr Opin HIV AIDS; 2011 Dec; 6 Suppl 1():S1-2. PubMed ID: 22156774
[No Abstract] [Full Text] [Related]
9. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
10. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in antiretroviral treatment and prevention in HIV-infected patients.
Maltêz F; Doroana M; Branco T; Valente C
Curr Opin HIV AIDS; 2011 Dec; 6 Suppl 1():S21-30. PubMed ID: 22156776
[TBL] [Abstract][Full Text] [Related]
12. Optimizing HIV treatment programs.
Bautista-Arredondo S; Martz TE; Wirtz VJ; Bertozzi SM
Curr Opin HIV AIDS; 2010 May; 5(3):232-6. PubMed ID: 20539079
[TBL] [Abstract][Full Text] [Related]
13. HIV-2 down, HIV-1 to go? Understanding the possibilities of treatment as prevention.
Bruhn CA; Gilbert MT
Lancet Infect Dis; 2011 Apr; 11(4):260-1. PubMed ID: 21453865
[No Abstract] [Full Text] [Related]
14. HIV treatment as prevention: [corrected] next steps.
Duerr A
Curr Opin HIV AIDS; 2012 Mar; 7(2):97-8. PubMed ID: 22241162
[No Abstract] [Full Text] [Related]
15. Treatment as prevention: translating efficacy trial results to population effectiveness.
Garnett GP; Becker S; Bertozzi S
Curr Opin HIV AIDS; 2012 Mar; 7(2):157-63. PubMed ID: 22258503
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
17. Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load.
Celum CL; Buchbinder SP; Donnell D; Douglas JM; Mayer K; Koblin B; Marmor M; Bozeman S; Grant RM; Flores J; Sheppard HW
J Infect Dis; 2001 Jan; 183(1):23-35. PubMed ID: 11106536
[TBL] [Abstract][Full Text] [Related]
18. Modelling the impact of treatment with individual antiretrovirals.
Cambiano V; Phillips AN
Curr Opin HIV AIDS; 2011 Mar; 6(2):124-30. PubMed ID: 21505387
[TBL] [Abstract][Full Text] [Related]
19. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
20. [News in HIV/AIDS therapy].
Calmy A; Cavassini M
Rev Med Suisse; 2012 Jan; 8(324):130-4. PubMed ID: 23185824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
